Resectable Lung Non-Small Cell Carcinoma

specific

Lung non-small cell carcinoma that is amenable to surgical resection.

33

Centers

34

Active Trials

Cancer Funding

Top Centers for Resectable Lung Non-Small Cell Carcinoma(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.3
2
NCI Comprehensive
Active Research Program
50.8
3
NCI Comprehensive
Active Research Program
50.8
4
NCI Comprehensive
Active Research Program
50.8
5
NCI Comprehensive
Active Research Program
50.8
6
NCI Comprehensive
Active Research Program
50.8
7
NCI Comprehensive
Active Research Program
50.8
8
NCI Comprehensive
Active Research Program
50.8
950.8
10
NCI Comprehensive
Active Research Program
50.8
11
NCI Comprehensive
Active Research Program
50.8
12
NCI Comprehensive
Active Research Program
50.8
13
NCI Comprehensive
Active Research Program
50.8
14
NCI Comprehensive
Active Research Program
50.8
15
NCI Clinical
Active Research Program
50.8
16
NCI Comprehensive
Active Research Program
50.8
17
Active Research Program
50.8
18
NCI Clinical
Active Research Program
50.8
19
NCI Clinical
Active Research Program
50.8
20
NCI Comprehensive
Active Research Program
50.8
21
NCI Comprehensive
Active Research Program
50.8
22
Active Research Program
50.8
23
NCI Clinical
Active Research Program
50.8
24
NCI Comprehensive
Active Research Program
50.8
25
Active Research Program
50.8
26
Active Research Program
50.8
2750.8
28
Active Research Program
50.8
29
Active Research Program
50.8
30
Active Research Program
50.8
31
Active Research Program
50.8
32
Active Research Program
50.8
33
Active Research Program
50.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →